Azelnidipine, a new long-acting calcium-channel blocker, inhibits tumour necrosis factor-α-induced monocyte chemoattractant protein-1 expression in endothelial cells

T. Matsui, Shoichi Yamagishi, K. Nakamura, H. Inoue

Research output: Contribution to journalArticlepeer-review

13 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Azelnidipine, a new long-acting calcium-channel blocker, inhibits tumour necrosis factor-α-induced monocyte chemoattractant protein-1 expression in endothelial cells'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds